Blueprint Medicines (BPMC) PT Raised to $136 at Wedbush

April 13, 2021 6:19 AM EDT
Get Alerts BPMC Hot Sheet
Price: $84.55 -1%

Rating Summary:
    13 Buy, 6 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 12 | New: 23
Trade Now! 
Join SI Premium – FREE
Wedbush analyst David Nierengarten raised the price target on Blueprint Medicines (NASDAQ: BPMC) to $136.00 (from $119.00) while maintaining a Outperform rating.

You May Also Be Interested In

Related Categories

Analyst PT Change